Topical capecitabine for the treatment of hyperproliferative skin conditions
US11559541B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2019 |
| Grant date | Jan 24, 2023 |
| Priority date | — |
| Expiry date | Feb 1, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel and unexpected method of using topical Capecitabine composition to obtain therapeutically effective amounts of fluorouracil (FU) within the skin of a subject afflicted with hyperproliferative or inflammatory skin condition. The method comprising topically administering a pharmaceutical composition comprising Capecitabine or a hydrate or solvate thereof to the affected area of the skin of the subject, to form therapeutically effective amounts of FU within the skin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.